Clincosm LogoSign in Get a demo

Graft Versus Host Disease

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD, GVHD, Acute-graft-versus-host Disease Trial in Canada, United States (Itolizumab, EQ001 Placebo)

Recruiting
  • Graft Versus Host Disease
  • +4 more
  • Itolizumab
  • EQ001 Placebo
  • Duarte, California
  • +5 more
Jul 5, 2022

GVHD Trial in United States (Abatacept)

Recruiting
  • Graft Versus Host Disease
  • Birmingham, Alabama
  • +8 more
Mar 16, 2022

Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

Active, not recruiting
  • Sickle Cell Disease
  • Graft Versus Host Disease
  • Washington, District of Columbia
  • +6 more
Aug 4, 2021

GVHD Trial in Boston (Interleukin-2)

Completed
Has Results
  • Graft Versus Host Disease
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jun 22, 2020

GVHD Trial in Boston (Natalizumab, Methylprednisolone)

Completed
Has Results
  • Graft Versus Host Disease
  • Boston, Massachusetts
  • +1 more
Apr 7, 2020

GVHD Trial in United States (Ibrutinib)

Completed
Has Results
  • Graft Versus Host Disease
  • Duarte, California
  • +9 more
Jun 14, 2019

GVHD Trial in Boston (LDE225)

Terminated
  • Graft Versus Host Disease
  • Boston, Massachusetts
  • +2 more
Mar 15, 2018

GVHD Trial in Boston (Tacrolimus, Methotrexate, Bortezomib)

Completed
Has Results
  • Graft Versus Host Disease
  • Boston, Massachusetts
  • +3 more
Jun 20, 2017

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 20, 2017

GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 30, 2017

GVHD Trial in United States (Daclizumab, methylprednisolone, Placebo)

Completed
  • Graft Versus Host Disease
  • Daclizumab
  • +2 more
  • Boston, Massachusetts
  • +7 more
Jan 19, 2017

GVHD, Lymphoma Trial in United States (carmustine, melphalan, etoposide)

Completed
  • Graft Versus Host Disease
  • Lymphoma
  • Birmingham, Alabama
  • +47 more
Jul 15, 2016

GVHD, GVHD Trial in Boston (tacrolimus, sirolimus, fludarabine)

Completed
Has Results
  • Graft Versus Host Disease
  • GVHD
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 29, 2014

GVHD Trial in Worldwide (cyclosporine, hydroxychloroquine, prednisone)

Completed
  • Graft Versus Host Disease
  • Tucson, Arizona
  • +103 more
Feb 12, 2014

GVHD Trial in Boston (Opebacan)

Terminated
  • Graft Versus Host Disease
  • Boston, Massachusetts
    (unnamed)
Jul 27, 2012

GVHD, Hematologic Malignancies Trial in Boston (Sirolimus, Tacrolimus, Methotrexate)

Completed
  • Graft Versus Host Disease
  • Hematologic Malignancies
  • Boston, Massachusetts
  • +2 more
Mar 6, 2012

Acute Myelogenous Leukemia, GVHD, Acute Lymphoblastic Leukemia Trial in Boston (sirolimus, tacrolimus)

Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • Boston, Massachusetts
    Dana-Farber Cancer Center
Jan 24, 2012